Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | ARCT | COGT | ||
| Company | Anaptysbio Inc | Arcturus Therapeutics Ltd | Cogent Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.60 | 27.06 | 7.60 | ||
| High | 26.63 | 27.90 | 7.71 | ||
| Low | 25.65 | 26.73 | 7.48 | ||
| Last | 25.45 | 27.06 | 7.46 | ||
| Change | -1.13 | -0.21 | -0.07 | ||
| % Change | -4.25% | -0.77% | -0.93% | ||
| Volume | 63,184 | 126,296 | 414,908 | ||
| 20-Day Average Volume | 422,496 | 517,768 | 1,361,493 | ||
| Previous Close | 26.58 | 27.27 | 7.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.16 | 28.08 | 6.73 | ||
| 20-Day Raw Stochastic | 84.76% | 21.69% | 90.22% | ||
| 20-Day Relative Strength | 59.79% | 42.25% | 58.55% | ||
| Weighted Alpha | +31.63 | -21.08 | -30.47 | ||
| Today's Opinion | 72% Buy | 56% Sell | 8% Buy | ||
| Previous Opinion | 72% Buy | 56% Sell | 8% Buy | ||
| Last Month's Opinion | 24% Buy | 24% Buy | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +20.75% since 04/29/24 | +1.69% since 04/29/24 | +12.37% since 04/29/24 | ||
| Low | 21.02 on 04/30/24 | 25.44 on 04/30/24 | 6.43 on 04/30/24 | ||
| High | 27.02 on 05/03/24 | 28.42 on 05/01/24 | 7.72 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +22.01% since 04/05/24 | -15.30% since 04/05/24 | +12.37% since 04/05/24 | ||
| Low | 18.49 on 04/25/24 | 25.41 on 04/25/24 | 5.88 on 04/25/24 | ||
| High | 27.02 on 05/03/24 | 33.11 on 04/11/24 | 7.72 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | +7.08% since 02/06/24 | -28.26% since 02/06/24 | +25.04% since 02/06/24 | ||
| Low | 18.49 on 04/25/24 | 25.41 on 04/25/24 | 5.37 on 02/13/24 | ||
| High | 27.50 on 02/26/24 | 43.81 on 02/27/24 | 10.26 on 02/22/24 | ||
| 6-Month | |||||
| %Chg | +54.29% since 11/06/23 | +47.01% since 11/06/23 | -9.70% since 11/06/23 | ||
| Low | 13.36 on 11/28/23 | 17.52 on 11/13/23 | 3.67 on 12/11/23 | ||
| High | 27.50 on 02/26/24 | 43.81 on 02/27/24 | 10.26 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 726,139 | 734,326 | 719,966 | ||
| Shares Outstanding, K | 27,319 | 26,928 | 95,613 | ||
| Annual Sales | 17,160,000 | 166,800,000 | 0 | ||
| Annual Net Income | -163,620,000 | -29,730,000 | -192,410,000 | ||
| Last Quarter Sales | 9,010,000 | 30,860,000 | 0 | ||
| Last Quarter Net Income | -42,210,000 | -11,710,000 | -54,360,000 | ||
| 60-Month Beta | -0.32 | 2.65 | 1.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.59 on 03/11/24 | -0.32 on 03/07/24 | -0.63 on 02/26/24 | ||
| Latest Earnings Date | 05/09/24 | 05/08/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 01/04/13 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||